- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2662-8651
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Targeting regulatory T cells for immunotherapy in melanoma ; volume:2 ; number:1 ; day:19 ; month:4 ; year:2021 ; pages:1-15 ; date:12.2021
Molecular biomedicine ; 2, Heft 1 (19.4.2021), 1-15, 12.2021
- Urheber
-
Huang, Lili
Guo, Yeye
Liu, Shujing
Wang, Huaishan
Zhu, Jinjin
Ou, Lingling
Xu, Xiaowei
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s43556-021-00038-z
- URN
-
urn:nbn:de:101:1-2021060612094471361368
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Huang, Lili
- Guo, Yeye
- Liu, Shujing
- Wang, Huaishan
- Zhu, Jinjin
- Ou, Lingling
- Xu, Xiaowei
- SpringerLink (Online service)
Ähnliche Objekte (12)
New strategies for cancer immunotherapy: targeting regulatory T cells
IL-2 immunotherapy for targeting regulatory T cells in autoimmunity
Metabolic targeting of regulatory T cells in oral squamous cell carcinoma: new horizons in immunotherapy
Immunotherapy targeting esophageal cancer stem cells
Harnessing proteases for T regulatory cell immunotherapy
Immunotherapy of malignant melanoma
Regulatory cells and the effect of cancer immunotherapy
Specifically targeting ERK1 or ERK2 kills Melanoma cells
Novel vaccination strategies for CD4+ T cell immunotherapy of melanoma
Optimization of engineered T cells for the use in melanoma immunotherapy
Fibrin-Targeting Immunotherapy for Dementia
Targeting STAT3 in Cancer Immunotherapy
New strategies for cancer immunotherapy: targeting regulatory T cells
IL-2 immunotherapy for targeting regulatory T cells in autoimmunity
Metabolic targeting of regulatory T cells in oral squamous cell carcinoma: new horizons in immunotherapy
Immunotherapy targeting esophageal cancer stem cells
Harnessing proteases for T regulatory cell immunotherapy
Immunotherapy of malignant melanoma
Regulatory cells and the effect of cancer immunotherapy
Specifically targeting ERK1 or ERK2 kills Melanoma cells
Novel vaccination strategies for CD4+ T cell immunotherapy of melanoma
Optimization of engineered T cells for the use in melanoma immunotherapy
Fibrin-Targeting Immunotherapy for Dementia
Targeting STAT3 in Cancer Immunotherapy
New strategies for cancer immunotherapy: targeting regulatory T cells
IL-2 immunotherapy for targeting regulatory T cells in autoimmunity
Metabolic targeting of regulatory T cells in oral squamous cell carcinoma: new horizons in immunotherapy
Immunotherapy targeting esophageal cancer stem cells
Harnessing proteases for T regulatory cell immunotherapy
Immunotherapy of malignant melanoma
Regulatory cells and the effect of cancer immunotherapy
Specifically targeting ERK1 or ERK2 kills Melanoma cells
Novel vaccination strategies for CD4+ T cell immunotherapy of melanoma
Optimization of engineered T cells for the use in melanoma immunotherapy
Fibrin-Targeting Immunotherapy for Dementia